[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-CUE":3,"homepage-market-summary":31,"stock-news-CUE":172},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"CUE","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Cue Biopharma, Inc.","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.","29","Boston, MA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":20,"change":21,"percent_change":22,"volume":23,"transactions":24,"vwap":25,"high_52w":26,"low_52w":27,"avg_volume_52w":28,"range_52w_percent":29,"record_count":30},25.57,25.6,25.92,24.67,25.25,0.32,1.27,156827.245456,3196,25.4419,45.5,4.98,276208.107568256,50.8,2200,{"status":32,"indices":33,"watchlist":77,"sectors":99,"benchmarks":154},"success",[34,42,49,56,63,70],{"symbol":35,"name":36,"price":37,"change":38,"pct_change":39,"is_up":40,"sparkline":41,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":43,"name":44,"price":45,"change":46,"pct_change":47,"is_up":40,"sparkline":48,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":50,"name":51,"price":52,"change":53,"pct_change":54,"is_up":40,"sparkline":55,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":57,"name":58,"price":59,"change":60,"pct_change":61,"is_up":40,"sparkline":62,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":64,"name":65,"price":66,"change":67,"pct_change":68,"is_up":40,"sparkline":69,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":71,"name":72,"price":73,"change":74,"pct_change":75,"is_up":14,"sparkline":76,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[78,85,92],{"symbol":79,"name":80,"price":81,"change":82,"pct_change":83,"is_up":40,"sparkline":84,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":86,"name":87,"price":88,"change":89,"pct_change":90,"is_up":40,"sparkline":91,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":93,"name":94,"price":95,"change":96,"pct_change":97,"is_up":40,"sparkline":98,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[100,105,110,115,120,125,130,135,140,144,149],{"name":101,"etf":102,"change":103,"price":104,"is_up":40},"Technology","XLK",1.01,199.81,{"name":106,"etf":107,"change":108,"price":109,"is_up":40},"Financials","XLF",0.06,53.49,{"name":111,"etf":112,"change":113,"price":114,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":116,"etf":117,"change":118,"price":119,"is_up":40},"Consumer Cycl","XLY",1.13,110.04,{"name":121,"etf":122,"change":123,"price":124,"is_up":40},"Consumer Staples","XLP",0.25,80.53,{"name":126,"etf":127,"change":128,"price":129,"is_up":40},"Energy","XLE",0.4,62.95,{"name":131,"etf":132,"change":133,"price":134,"is_up":40},"Industrials","XLI",0.78,169.95,{"name":136,"etf":137,"change":138,"price":139,"is_up":40},"Materials","XLB",0.66,48.86,{"name":141,"etf":142,"change":21,"price":143,"is_up":40},"Real Estate","XLRE",40.81,{"name":145,"etf":146,"change":147,"price":148,"is_up":40},"Utilities","XLU",0.38,39.83,{"name":150,"etf":151,"change":152,"price":153,"is_up":40},"Comm Services","XLC",0.35,110.32,[155,160,164,168],{"ticker":156,"name":157,"price":158,"change":159,"is_up":40},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":161,"name":162,"price":163,"change":90,"is_up":40},"QQQ","Invesco QQQ Trust",749.58,{"ticker":165,"name":166,"price":167,"change":54,"is_up":40},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":169,"name":170,"price":171,"change":68,"is_up":40},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":173,"articles":174},20,[175,181,187,192,197,203,209,215,221,227,233,238,242,244,249,254,259,264,270,275],{"title":176,"link":177,"pubDate":178,"description":179,"source":180},"$CUE stock is down 28% today. Here's what we see in our data. - quiverquant.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMioAFBVV95cUxOSVJIRjNzeHYwT2YySDdhY0JPMHpEcnJzbWNhOXVoRGlUYTdzMk5IS1B4V3BjdF9wUzdnMzJwNzMwMUhjSnZnTU5sOTU3ajc5X2NxdWFMVUp3Ny1iWnE1V280cFJzNHRvQ0VaekgyTmd0eGxBVlN1M2NVbkEtSGhUTTJtTkdkTGd2ckRzU1QzYjZta19YU1ZZVi1TNXRiTGZl?oc=5","Mon, 21 Sep 2026 14:52:00 GMT","$CUE stock is down 28% today. Here's what we see in our data. quiverquant.com","quiverquant.com",{"title":182,"link":183,"pubDate":184,"description":185,"source":186},"Cue Biopharma Shares Jump 41.6% Premarket Following Phase 2 Trial Results - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikwFBVV95cUxPZFQteFVnRzUzOVpIN0cxZENRNXdPT2pkMWkzelMtQ2ppM3g0b0Mwck9pWU80TDZ3RDA4Q2JTTDQ5RkhVTDAzWGJkV2dQQ1VQU3lVWldscnJkR29sMzRQS0prUDJFS002V1JZeko4UVNrd2hJVG1QTnNYTEhzU0h6dGpiOEdDSDVSRUl3SlVaWG5VWlk?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","Cue Biopharma Shares Jump 41.6% Premarket Following Phase 2 Trial Results Yahoo Finance","Yahoo Finance",{"title":188,"link":189,"pubDate":184,"description":190,"source":191},"Why is Cue Biopharma stock surging today? - Investing.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMipAFBVV95cUxQUFNfTjdZT2hQVmxZWlo1VkdUbWhqbVAyRzVOc3NIcWtrdmRBZlhzQnR2ME5uQ0hQZUFOQ0h4V2h4bmZLaGpXdGRpNzlXTGpaNW5rRWpELWxMUEZGSmdQbUNZVGktLVR0QWJqbGNkaEctdWQwLTVjT3dyNHpIbVprQ2t0QWtkUHo3MV9fT0VpalJlVkhrMzdnUEU0VUNQS25HSnJvcQ?oc=5","Why is Cue Biopharma stock surging today? Investing.com","Investing.com",{"title":193,"link":194,"pubDate":184,"description":195,"source":196},"Cue Biopharma: Initiating 'Buy' Based On CUE-221 Trial Win For CSU With Novel Dual MOA - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivAFBVV95cUxNdG5lb0JtUlVhVGJiR05mZnJuSjUzTUx2TmIzVXY3V2FvWjBBcjJ1cVUwTlJ2Tm50TjhjVElWa0FNUmlHalJHUHBLQzh6ZHJIWHlSaXdYVkxDdFZGY0cxOC1SekF4TU5lZ1ZtS3paRWRhWFVzMlhOdm5pLWs0d3k2Q1VhdlNTZEphSmFMdmlpeTFrdTJiY3hGRGpjSU16YlhJS0pmWnIxWmI4NHduYjhIR1cyUXprX1V4MjFYbg?oc=5","Cue Biopharma: Initiating 'Buy' Based On CUE-221 Trial Win For CSU With Novel Dual MOA Seeking Alpha","Seeking Alpha",{"title":198,"link":199,"pubDate":200,"description":201,"source":202},"Understanding the Setup: (CUE) and Scalable Risk - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxOcUwzSTYwYUpUNWliR2s4UFBjb2p6TG5yVU9VWnIyRVF3T3dyYUJSYTRuOWhVOUlfVzRFREJlTDZCQnJPSjhadFN1TXQycTQyLUFndXQxZV9Lc2R0VDV0OUJnV2JMck56cGhhTFdkRmZ4eDItSnpnbldORjN4MUdEM3g4STdhWnMxQ1Y3aWpRZjFIcnJLVXVLblZhN09DSk1VbzNUekU2MVNDYVprOHFvRVpydVljM0luMU1MMnhndVl0Ukk?oc=5","Sun, 27 Sep 2026 14:34:02 GMT","Understanding the Setup: (CUE) and Scalable Risk Stock Traders Daily","Stock Traders Daily",{"title":204,"link":205,"pubDate":206,"description":207,"source":208},"Cue Biopharma (CUE) Retreats 7.07% to $25.51, Sitting at the Midpoint of Its Recent Range - Wide Range Bar - siam.in","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxNaU9XMEFaeHVfdkN1b3NNSWppUHlka3RlYkNZWTBoNUlTQ1B2bXRnVjR5a2hvZ2FfalNOWlZzZWdQZ1VrdmYxM0RMMjd5NHp3RXQyRUtZbGk0eUY4MG14NkVfTlZyME02dThrbkFiaXhvVjg3NHl3ZUFuWjhUeDhCYnE4ekhJTk42VTNXTFRjc1R2S0hVblNpZTktWjUtaEw1MmNITUU3ZzdteWY1ZElQMXB2ZVJNd2VsMFN6RjgtdGc1WWs?oc=5","Wed, 30 Sep 2026 13:36:25 GMT","Cue Biopharma (CUE) Retreats 7.07% to $25.51, Sitting at the Midpoint of Its Recent Range - Wide Range Bar siam.in","siam.in",{"title":210,"link":211,"pubDate":212,"description":213,"source":214},"AAPL Stock Hits Record Highs — Apple Reportedly Explores Screenless Health Trackers And Other Wearables Following iPhone Duo Launch - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimAJBVV95cUxQaUpPWUlteXIxMG52cS1ERm4tSDlRY1ltTkFQWWhiaFBfS1NnSi1hVE04TDFSY3dRY0REeFg2ZFdsYVllOWxYNndyV0N2dDNYM05nWXFCRmt6UDdUbm1hTTdpWHg4Z0k2T0RTUkQ4OWFGVlFubXhFbkdFbVFIaWhlaWNYaFBid2lSMFJtQ2k3WXRhZUlyR1hmUlRXcUlYWV9aMzBlT3V4QXVsN01EVjFkdkVlVi1WT09GalpoM1F4V1NVV3UtT182TFRuZjFGZEdnOGlsNUdKbmpMcllBRDBfaDJCclFWSzFCNGdLbjdQYVR2UWNOTURiRENzRzhWcmpvTXZGUmUyY3FKbElXRl91dnM0c01iOTgz?oc=5","Tue, 22 Sep 2026 18:04:19 GMT","AAPL Stock Hits Record Highs — Apple Reportedly Explores Screenless Health Trackers And Other Wearables Following iPhone Duo Launch TradingView","TradingView",{"title":216,"link":217,"pubDate":218,"description":219,"source":220},"GOOGL, AMZN, SNDK Stocks Hit 52-Week Highs Today: What's Fueling The Rally? - stocktwits.com","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi0gFBVV95cUxOcHVtbEVCaXN4ZV9QNFczZ29VSXRDYkxJRDZHSE9nTG1iS2xzSFNDSG5jR2xqeV9HOGhQY005aE5TS2tobjN1ZENGM3B6MjRxQkJscnAwdTBzb1BNOWlSaEVhU1dZSnhpQXV1cE1mQ3dzMy1lMzRJRzdyQ0VnN0xDdE84eUNSblRkR3JSNTVxXzBYdjN6Yk1UMnBLdHEyRFVHVE9SbE1NQmhqY3BFUk9wV3k4NWYyN1BaMnZFRW5HSGJOR014c2twV05pVnNRcW41RkE?oc=5","Sat, 03 Oct 2026 18:55:50 GMT","GOOGL, AMZN, SNDK Stocks Hit 52-Week Highs Today: What's Fueling The Rally? stocktwits.com","stocktwits.com",{"title":222,"link":223,"pubDate":224,"description":225,"source":226},"Seoul stocks open higher on chip gains - The Korea Herald","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiV0FVX3lxTE9Xa1hjS3h4Q3dKM2pnRG02eFh6NmFxdGhsdTR3N05INllZSzd6YlkxRGJ3WkF3QkJvRDJld2JSdGx3TVdQbUNWS1FHY1FQNVJlOG5URDQwYw?oc=5","Wed, 30 Sep 2026 00:31:45 GMT","Seoul stocks open higher on chip gains The Korea Herald","The Korea Herald",{"title":228,"link":229,"pubDate":230,"description":231,"source":232},"B.Riley reiterates Cue Biopharma stock rating on allergy data By Investing.com - Investing.com Nigeria","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivgFBVV95cUxPQWUzeDlCOFBOZ2x4cDhrVi10TUgwVi1YM1lYeENTQVVMajdWZkJ0ckZYN21HWGRfRXZubjA3OWFReHZlRVktc3U0YmJ3NVZTSzM3bm1fUWJ5U0FsQUdOVEJEaDJJcWtPT2RneHNXUC10NWV1SGN6NjAwVHJ5VWlyMWJCRUZscDVDZnJUZDdzcjNfb1BOOFFjajE0T0J4Ul95bHZyNGV3TUdXWGo2MXowOWpxb1pvYjk1NlhGTkJ3?oc=5","Thu, 01 Oct 2026 12:47:45 GMT","B.Riley reiterates Cue Biopharma stock rating on allergy data By Investing.com Investing.com Nigeria","Investing.com Nigeria",{"title":234,"link":235,"pubDate":236,"description":237,"source":186},"Top Premarket Gainers - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMijwFBVV95cUxQd0UwMnkxczNOUXNlMXlMSU9sZjNlcTE2bS1kUjVkdVFvdXo2X0d5a1pFdDhRdmJGV0lINUc2Vm41bE5tZ2x4SHlxbjN1NmNHdkh6VTNqV3dsekpMS1dhQWttbjlGZGVGMC13aVo4NktsS2JyUk4xMUpobW9LbTgxOEFPdkFJUlBYUl9JUXpkZw?oc=5","Mon, 21 Sep 2026 11:02:17 GMT","Top Premarket Gainers Yahoo Finance",{"title":239,"link":240,"pubDate":184,"description":241,"source":196},"Cue Biopharma plummets on phase 2 data for chronic spontaneous urticaria asset - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMirgFBVV95cUxQXzVRSXFvVnYwNjJIUzdUWVJTZkVMWUt0T0t3S1VPd0JtOWJTTVVhSWpLMVE4dDRpY3dWeDY0QS1aZjVZc3UwbjVQbF9od19jdXUzazVtMHFRUkZ3bmx0M2VRMldCZDJlcEZZVmNxLUxNRTdjS0FneUhSejFvekVNYjVVR1M3WmpOZkk1OU5raXdEX2dVTmtwVkd3cmpTcERkM0dyd3A1RDR4RVlhdmc?oc=5","Cue Biopharma plummets on phase 2 data for chronic spontaneous urticaria asset Seeking Alpha",{"title":222,"link":243,"pubDate":184,"description":225,"source":226},"https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiV0FVX3lxTE9aN0NLSlRTbV9SclNQVXgyM2VxcHFOWEthdXd4UGZDNVVrQUFVZnNENzVKWFl6ZTRWZ1VhVFJXTDlnMm5oczdWanhDWXRlNVdWR1VIQkFzcw?oc=5",{"title":245,"link":246,"pubDate":247,"description":248,"source":186},"Cue Biopharma’s CUE-221 Hits Phase II Goals, Shows Durable CSU Response - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMikAFBVV95cUxQdTFNcTZqUkdqdHp3czYzYWZpbjNNd25YQ21SRERzMnVVM29NVGllbzZkWVNYN0E1ejZHSzRBMXVWQWdmQnJfelFROE5xWXd2OGI1UDJETVBGaHBlcGpaWGd5bWtOYUctNmR5RTlIclBZTXhhQ3V5LXBtWlBNUlBxNU53U244VFM4ajRIYW1SX1I?oc=5","Mon, 28 Sep 2026 09:02:14 GMT","Cue Biopharma’s CUE-221 Hits Phase II Goals, Shows Durable CSU Response Yahoo Finance",{"title":250,"link":251,"pubDate":252,"description":253,"source":196},"Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria - Slideshow (NASDAQ:CUE) 2026-09-24 - Seeking Alpha","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMixgFBVV95cUxPTVJOU2pTY05INEdGNmdTMTZiVkNtWmRqRkVFTS1xRGx5ZEplVkxiMW1obmdUdkJRVF9CRVBkSUJ4d2U4Y2EyZWJjbnBzQUtqa0FjNzVtYW5rUGt2UEExTWZkbW4tVG9RMnlQTEhkM0ZWV2xUSGdfVDZ5eXZPNFBHR3JnemtfV0E5MlRnWDZvTXZtRWxTY0l2cE1Sdnl5UWNic0ZXYXhCbjdoZWNTZGk1R3RIbDRLZ1kyN1BORUFJeks3QTdlcmc?oc=5","Thu, 24 Sep 2026 07:00:00 GMT","Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria - Slideshow (NASDAQ:CUE) 2026-09-24 Seeking Alpha",{"title":255,"link":256,"pubDate":257,"description":258,"source":186},"Cue Biopharma (CUE) Reports Hives Drug Results. Can Longer Relief Set it Apart? - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilwFBVV95cUxNVjJMYkpxSmRpdDd5dlhjc2lNYkgxUW03S1pNQ2pnWGVzSUVsMUFKTGhBTWhyUUx0XzZaOFBiZjZiNlBWMERKMzhhWG5mTUo3MXNiSFk5TDJkVEwzbWZ6QkoxZFJGQV9uZ2VFaUN4cFgyeEstRlNWSHJrUHBJS3l3aUhNdTNKVmxPUV8xcjlFck9kZ3ltWkww?oc=5","Fri, 25 Sep 2026 07:00:00 GMT","Cue Biopharma (CUE) Reports Hives Drug Results. Can Longer Relief Set it Apart? Yahoo Finance",{"title":260,"link":261,"pubDate":262,"description":263,"source":186},"Act Now: Micron Could Skyrocket After Sept. 30 - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimwFBVV95cUxNY2hzSlFzeTNQaDFtYThKTWxZdS1ubmNUSzZTSmFCaUNOazUzcXE3cHhYUERzRk9MVU1ZNVlPUkR1ZmdOQWZxWHJJaDhpSGpsM3hYYmhiOWdxNWE1QXpUWWt0X2RONE9lck40Q08xVWNDbFlydmdNS0VMVXVVbFVnU28tTjFtTTd3Q0VKaEZlWEtDU2NXS2VRbWRUcw?oc=5","Wed, 23 Sep 2026 07:00:00 GMT","Act Now: Micron Could Skyrocket After Sept. 30 Yahoo Finance",{"title":265,"link":266,"pubDate":267,"description":268,"source":269},"Cue Biopharma stock swings after positive CUE-221 Phase 2 data and profit-taking - AD HOC NEWS","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiwwFBVV95cUxQZGUxX1JXMlUzcGZNa0ZpMS1qank2SllrMmxtZnlpNm94WG5zOFc1NWRjOGxZaUd0ZWZ0anhWM3hhZUVRUk5xcWZVM3VENjg1MWdZWDFqOWU1NktxX0E1ZGV5bVFQdFlNQVlmbnBCbC05bFo0d0NUV0RZNno0QzdNSDlVQUpfV1JQUThSaWpzZmVnV2Q0UVAtNEtGSUtfaFcycldJRXkxR0IxY1Brb21lSzY2TWlORDFsb3dRR0ZCNW9uODA?oc=5","Tue, 22 Sep 2026 02:35:44 GMT","Cue Biopharma stock swings after positive CUE-221 Phase 2 data and profit-taking AD HOC NEWS","AD HOC NEWS",{"title":271,"link":272,"pubDate":184,"description":273,"source":274},"Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket - Benzinga","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMi2AFBVV95cUxOVlUzWDE1Z21MMXlLbmNTMXBXTklzNXlZbmFVaVhKUE5LeF9jRHJVc2JxNGxrY2hBSlRxOXhidG01SGoxMEpRaVlkQ3NDUml3c1lWNzdqYTJLNXZtYU1kdWR3ZkxRcFBmNzByZVdNb0tyeTBnd3ZkeDF0YXNzUHEyN1JieXMxZVJSTUNSeFZFbWFEX0VSMm5JVEVzNUVuQThqT1d4LTU5dFR6MFc3Sy1QamdvTC0wSzJWUjN2THBfSHlfVmZLSXVDR2JDRkMtazZ3Ukh5Z212WVM?oc=5","Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket Benzinga","Benzinga",{"title":276,"link":277,"pubDate":184,"description":278,"source":279},"Biotech stocks and leveraged ETFs lead market d... - Pluang","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiggFBVV95cUxPNG9PcnVSU01BZ2VOblcyTUhyNmwzMjlaR1lTbXBxMDJ5eVNxZ2o2UGJKeVNTVGdiNE8zWnc4VHUzY2tVUFR6QXI0cUMzMVFBcW9rbnYxXzVYS2hJemtHS21CdWltdGtZbXY0Uy1KemxaVVA0el9XS3F3X2NnU3k5bXlR?oc=5","Biotech stocks and leveraged ETFs lead market d... Pluang","Pluang"]